Article Type
Article
Changed
Fri, 01/04/2019 - 11:11
Display Headline
BEST PRACTICES IN: Oral Cancer Therapies: Important Prescribing Considerations

A supplement to The Journal of Community and Supportive Oncology. This supplement was sponsored by Novartis Pharmaceuticals.

To view the supplement, click the image to the right

Sponsor
Sponsored by Novartis Pharmaceuticals
Article PDF
BP_JCSO_Oral_CA_Prescribing_090115.pdf
Publications
The Journal of Community and Supportive Oncology
MDedge Hematology and Oncology
Sections
Supplements
Article PDF
BP_JCSO_Oral_CA_Prescribing_090115.pdf
Article PDF
BP_JCSO_Oral_CA_Prescribing_090115.pdf
Sponsor
Sponsored by Novartis Pharmaceuticals
Sponsor
Sponsored by Novartis Pharmaceuticals

A supplement to The Journal of Community and Supportive Oncology. This supplement was sponsored by Novartis Pharmaceuticals.

To view the supplement, click the image to the right

A supplement to The Journal of Community and Supportive Oncology. This supplement was sponsored by Novartis Pharmaceuticals.

To view the supplement, click the image to the right

Publications
The Journal of Community and Supportive Oncology
MDedge Hematology and Oncology
Publications
The Journal of Community and Supportive Oncology
MDedge Hematology and Oncology
Article Type
Article
Display Headline
BEST PRACTICES IN: Oral Cancer Therapies: Important Prescribing Considerations
Display Headline
BEST PRACTICES IN: Oral Cancer Therapies: Important Prescribing Considerations
Sections
Supplements
Disallow All Ads
Alternative CME
Teaser Media
Article PDF Media